SONN - Sonnet BioTherapeutics Holdings, Inc.

QQQ $ 474.86 $ 2.12 (0.45 %)

DIA $ 414.87 $ 2.97 (0.72 %)

SPY $ 561.82 $ 2.92 (0.52 %)

TLT $ 100.40 $ 0.27 (0.27 %)

GLD $ 238.66 $ 2.35 (0.99 %)

Previous Close

$ 0.8105

Open

$ 0.81

Bid

-- x --

Ask

-- x --

Day's Range

$ 0.81 - $ 0.81

52 Week Range

$ 0.62 - $ 3.80

Volume

14,200

Average Volume

Market Cap

4.22M

Beta (5Y Monthly)

$ 0.72

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	02-14-2024	12-31-2023	10-Q
4	12-14-2023	09-30-2023	10-K
5	08-14-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	02-13-2023	12-31-2022	10-Q
8	12-15-2022	09-30-2022	10-K
9	08-15-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	02-08-2022	12-31-2021	10-Q
12	12-17-2021	09-30-2021	10-K
13	08-16-2021	06-30-2021	10-Q
14	05-17-2021	03-31-2021	10-Q
15	02-16-2021	12-31-2020	10-Q
16	12-17-2020	09-30-2020	10-K
17	08-14-2020	06-30-2020	10-Q
18	05-18-2020	03-31-2020	10-Q
19	03-19-2020	12-31-2019	10-K
20	11-14-2019	09-30-2019	10-Q
21	08-14-2019	06-30-2019	10-Q
22	05-15-2019	03-31-2019	10-Q
23	04-01-2019	12-31-2018	10-K
24	11-14-2018	09-30-2018	10-Q
25	08-13-2018	06-30-2018	10-Q
26	05-15-2018	03-31-2018	10-Q
27	03-30-2018	12-31-2017	10-K
28	11-13-2017	09-30-2017	10-Q
29	08-14-2017	06-30-2017	10-Q
30	05-15-2017	03-31-2017	10-Q
31	03-31-2017	12-31-2016	10-K
32	11-10-2016	09-30-2016	10-Q
33	08-11-2016	06-30-2016	10-Q
34	05-16-2016	03-31-2016	10-Q
35	03-31-2016	12-31-2015	10-K
36	11-16-2015	09-30-2015	10-Q
37	08-14-2015	06-30-2015	10-Q
38	05-20-2015	03-31-2015	10-Q
39	04-15-2015	12-31-2014	10-K
40	11-14-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Chardan Capital Maintains Buy on Sonnet Bi...
08/23/2024 15:36:03

Chardan Capital analyst Keay Nakae maintains Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy and maintains $30 price target.

Sonnet BioTherapeutics Enters Into Clinica...
08/19/2024 12:46:30

Preclinical data has demonstrated the potential of SON-1210, the first albumin-binding bifunctional IL-12/IL-15 fusion protein,...

why-greenland-technologies-shares-are-trading-higher-by-around-40-here-are-20-stocks-moving-premarket

Why Greenland Technologies Shares Are Trad...
08/16/2024 10:55:55

Sonnet Biotherapeutics Filed U.S. Patent A...
08/15/2024 15:50:33

https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/20240269236?requestToken=eyJzdWIiOiI2NjBiODI3My0yYzg0LTQ2ZDItYT...

Sonnet BioTherapeutics Q3 2024 GAAP EPS $(...
08/14/2024 12:38:19

Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate o...

Sonnet BioTherapeutics Reports Data From P...
07/24/2024 12:33:14

Data indicates that SON-080 was well-tolerated at both doses, with no evidence of a pro-inflammatory cytokine responsePain and ...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
06/21/2024 12:08:00

Dow Jumps Over 300 Points; Zapp Electric V...
06/20/2024 18:35:07

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
06/20/2024 16:32:10

gold-rises-1-accenture-shares-surge-after-q3-results

Gold Rises 1%; Accenture Shares Surge Afte...
06/20/2024 16:00:55

dow-edges-lower-us-current-account-deficit-widens-in-q1

Dow Edges Lower; US Current Account Defici...
06/20/2024 13:42:46

Sonnet BioTherapeutics Announces Exercise ...
06/20/2024 12:41:39

Sonnet BioTherapeutics Announces Generatio...
06/13/2024 12:01:24

Sonnet discovered and characterized a modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhi...

Chardan Capital Maintains Buy on Sonnet Bi...
05/28/2024 10:52:14

Chardan Capital analyst Keay Nakae maintains Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy and maintains $30 price target.

EF Hutton Maintains Buy on Sonnet BioThera...
05/16/2024 18:24:33

EF Hutton analyst Tim Moore maintains Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy and lowers the price target from $11 t...

Sonnet BioTherapeutics Says Early Safety D...
03/11/2024 11:35:29

Sonnet BioTherapeutics Reported SON-1010 P...
02/29/2024 21:46:28

Sonnet BioTherapeutics Announces A Publica...
02/29/2024 21:25:30

Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for c...

Chardan Capital Maintains Buy on Sonnet Bi...
02/15/2024 17:35:18

Chardan Capital analyst Keay Nakae maintains Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy and lowers the price target fro...